Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Tomita N, Ohue M, Hayakawa T
Department of Neurosurgery, Osaka University Medical School, Japan.
Cancer Lett. 1997 Jan 30;112(2):251-6. doi: 10.1016/s0304-3835(96)04583-1.
Microsatellite instability has been reported in familial cancer syndrome and in various kinds of human sporadic tumors. We investigated the replication error (RER) and mutation rate of the transforming growth factor-beta type II receptor (TGF-beta RII) gene to determine the frequency of the RER+ phenotype and elucidate the relation between the mutation of the TGF-beta RII gene and RER in the tumorigenesis of glioma. We screened genomic DNA from 40 gliomas, comprised from 24 glioblastomas (GB), 11 anaplastic astrocytomas (AA) and five astrocytomas (AS) and compared the results with DNA from corresponding leukocytes. Seven of the 40 (18%) gliomas had the RER+ phenotype: five (21%) of 24 GB and two (18%) of 11 AA. In six gliomas we detected mutation of the TGF-beta RII gene. Five (71%) of seven RER+ and one (3%) of 33 RER-tumors had one A deletion in the (A)10 repeat of the TGF-beta RII gene. No mutations were detected in the (GT)3 repeat area of the TGF-beta RII gene. As the normal cells of these glioma patients had no mutations, we concluded that the mutations were somatic. We posit that the observed mutations inactivate the receptor through a frameshift mutation resulting in protein truncation. Our data suggest that the TGF-beta RII (A)10 repeat may be one area of genomic instability in the early stages of malignant glioma tumorigenesis.
微卫星不稳定性已在家族性癌症综合征和各类人类散发性肿瘤中被报道。我们研究了转化生长因子βⅡ型受体(TGF-βRII)基因的复制错误(RER)和突变率,以确定RER+表型的频率,并阐明TGF-βRII基因的突变与胶质瘤发生过程中RER之间的关系。我们筛选了40例胶质瘤的基因组DNA,其中包括24例胶质母细胞瘤(GB)、11例间变性星形细胞瘤(AA)和5例星形细胞瘤(AS),并将结果与相应白细胞的DNA进行比较。40例胶质瘤中有7例(18%)具有RER+表型:24例GB中有5例(21%),11例AA中有2例(18%)。在6例胶质瘤中我们检测到了TGF-βRII基因的突变。7例RER+肿瘤中有5例(71%)和33例RER-肿瘤中有1例(3%)在TGF-βRII基因的(A)10重复序列中有一个A缺失。在TGF-βRII基因的(GT)3重复区域未检测到突变。由于这些胶质瘤患者的正常细胞没有突变,我们得出结论这些突变是体细胞性的。我们推测观察到的突变通过移码突变使受体失活,导致蛋白质截短。我们的数据表明TGF-βRII(A)10重复序列可能是恶性胶质瘤发生早期基因组不稳定的一个区域。